Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Major Liver Resection
NCT01884948Phase 3Unknown
- Sponsor
- University of Zurich
- Start
- Jul 2013
- Primary completion
- Mar 2016
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in postoperative complications, sponsored by University of Zurich. Status: unknown.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT01884948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884948.